Poland· PL-100054197
Polfenon
A propafenone product containing propafenoni hydrochloridum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Propafenone is registered in 16 of 19 countries.
Countries holding a registration under ATC C01BC03 (propafenone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Propafenone · ATC C01BC03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of propafenone costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.23 in France to $0.68 in United States — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Propafenone · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- US United States$0.68 (acquisition cost)
- IT Italy$0.45
- ES Spain$0.28
- FR France$0.23
The record
At a glance
URPL (Poland)- Active substance
- Propafenoni hydrochloridum
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- C01BC03
- ATC class
- Propafenone
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
1 priced- gtin0590999003412320 szt.PLN 8.75
- gtin05909990034116
- gtin05909990034130
- gtin05909990034147
- gtin05909990933877
- gtin05903060616561
- gtin05903060616585
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
311 interactions on record for propafenone.
Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Propafenone · interactions on record
311 records
- 47 severe
- 192 moderate
- 7 minor
- 19 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Propafenone in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPROPAFENON ALSTADA Arzneimittel AG, Bad Vilbel
- United StatesPropafenone HClActavis Pharma, Inc.
- FinlandPropafenone Hydrochloride OrionOrion Corporation
- ItalyPROPAFENONERATIOPHARM GMBH
- BelgiumRytmonorm 150 mgTeva
- NetherlandsRytmonorm 150 mg, omhulde tablettenViatris Healthcare B.V.
- IrelandPropafenone Hydrochloride 150mg Film-coated tabletsAccord Healthcare Ireland Ltd.
- SwedenRytmonorm 150 mg Filmdragerad tablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Propafenon Accord, Rytmonorma
- Belgium · Rytmonorm
- Bulgaria · Пропастад, Пропафенон Алкалоид
- Cyprus · Propafenone Hydrochloride Accord Healthcare, Ρυθμονόρμ
- Czechia · Propafenon Al, Propanorm
- Germany · Propafenon Al, Propafenon Ratiopharm
- Denmark · Rytmonorm
- Estonia · Propafenone Accord, Propanorm
- Spain · Rytmonorm
- France · Propafenone Accord, Propafenone Viatris
- United Kingdom (Northern Ireland) · Arythmol, Propafenone Hydrochloride Accord
- Greece · Ρυθμονόρμ, Ρυθμονορμ Sr
- Croatia · Propafenon Alkaloid, Rytmonorm
- Hungary · Propafenon Al, Propafenon Pharmavit
- Ireland · Propafenone Hydrochloride Accord Healthcare Ireland
- Italy · Propafenone Accord, Propafenone Doc Generici
- Lithuania · Propafenone Accord, Propanorm
- Luxembourg · Rytmonorm
- Latvia · Propafenone Accord, Rytmonorm
- Malta · Propafenone Hydrochloride Accord Healthcare
- Netherlands · Rytmonorm
- Portugal · Propafenona Accord, Rytmonorm
- Romania · Propafenonă Al, Propafenonă Arena
- Sweden · Rytmonorm
- Slovenia · Propafenon Alkaloid-Int, Rytmonorm
- Slovakia · Propanorm, Rytmonorm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0620684e-74fb-40c3-995d-3d1a6036863e GET /v1/drugs/0620684e-74fb-40c3-995d-3d1a6036863e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "150 mg",
"packaging": "05909990034116 ¦ Rp ¦ Skasowane ¦ 8120\n20 tabl. w fiolce\n05909990034123 ¦ Rp ¦ 8121\n20 tabl.\n05909990034130 ¦ Rp ¦ Skasowane ¦ 8122\n60 tabl. w fiolce\n05909990034147 ¦ Rp ¦ Skasowane ¦ 8123\n60 tabl. w blistrach\n05909990933877 ¦ Rp ¦ 72406\n60 tabl.\n05903060616561 ¦ Rp ¦ 135356\n90 tabl.\n05903060616585 ¦ Rp ¦ 135357\n120 tabl.",
"substance": "Propafenoni hydrochloridum 150 mg",
"common_name": "Propafenoni hydrochloridum",
"pl_product_id": "100054197",
"pozwolenie_nr": "00341",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about propafenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.